Merck (MRK) Income from Continuing Operations (2009 - 2026)
Merck (MRK) reported Income from Continuing Operations of 4209000000.0 for Q1 2026, down 182.77% year-over-year from 5085000000.0 in Q1 2025, and down 242.1% on a QoQ basis from 2962000000.0 in Q4 2025.
Merck (MRK) has 18 years of Income from Continuing Operations data on file, last reported at 4209000000.0 in Q1 2026.
- Quarterly Income from Continuing Operations fell 182.77% year-over-year to 4209000000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 8968000000.0 (down 48.61% YoY) and the FY2025 annual result came in at 18263000000.0, up 6.6% from the prior year.
- Income from Continuing Operations eased to 4209000000.0 in Q1 2026 per MRK's latest filing, from 2962000000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 5787000000.0 in Q3 2025 and bottomed at 5937000000.0 in Q2 2023.
- The 5-year median for Income from Continuing Operations is 3744000000.0 (2024), against an average of 2713235294.12.
- The widest annual swing landed in 2023, when Income from Continuing Operations plunged 250.34%; it then jumped 405.38% in 2024.
- Tracing MRK's Income from Continuing Operations over 5 years: stood at 3018000000.0 in 2022, then plunged by 140.62% to 1226000000.0 in 2023, then jumped by 405.38% to 3744000000.0 in 2024, then fell by 20.89% to 2962000000.0 in 2025, then slumped by 242.1% to 4209000000.0 in 2026.
- Per Business Quant, the three latest MRK Income from Continuing Operations figures stand at 4209000000.0 (Q1 2026), 2962000000.0 (Q4 2025), and 5787000000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 7.40 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 5.24 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 697.00 Mn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -4.21 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 1.82 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 2.02 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 2.71 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 2.68 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.21 Bn |
| Dec 31, 2025 | 2.96 Bn |
| Sep 30, 2025 | 5.79 Bn |
| Jun 30, 2025 | 4.43 Bn |
| Mar 31, 2025 | 5.09 Bn |
| Dec 31, 2024 | 3.74 Bn |
| Sep 30, 2024 | 3.16 Bn |
| Jun 30, 2024 | 5.46 Bn |
| Mar 31, 2024 | 4.77 Bn |
| Dec 31, 2023 | -1.23 Bn |
| Sep 30, 2023 | 4.75 Bn |
| Jun 30, 2023 | -5.94 Bn |
| Mar 31, 2023 | 2.83 Bn |
| Dec 31, 2022 | 3.02 Bn |
| Sep 30, 2022 | 3.25 Bn |
| Jun 30, 2022 | 3.95 Bn |
| Mar 31, 2022 | 4.31 Bn |
| Dec 31, 2021 | 3.82 Bn |
| Sep 30, 2021 | 4.57 Bn |
| Jun 30, 2021 | 1.21 Bn |
| Mar 31, 2021 | 2.75 Bn |
| Dec 31, 2020 | -2.61 Bn |
| Sep 30, 2020 | 2.33 Bn |
| Jun 30, 2020 | 2.35 Bn |
| Mar 31, 2020 | 3.22 Bn |
| Dec 31, 2019 | -1.81 Bn |
| Sep 30, 2019 | 1.91 Bn |
| Jun 30, 2019 | 2.64 Bn |
| Mar 31, 2019 | 2.86 Bn |
| Dec 31, 2018 | 1.78 Bn |
| Sep 30, 2018 | 1.96 Bn |
| Jun 30, 2018 | 1.72 Bn |
| Mar 31, 2018 | 741.00 Mn |
| Dec 31, 2017 | -1.04 Bn |
| Sep 30, 2017 | -51.00 Mn |
| Jun 30, 2017 | 1.95 Bn |
| Mar 31, 2017 | 1.56 Bn |
| Dec 31, 2016 | -587.00 Mn |
| Sep 30, 2016 | 2.19 Bn |
| Jun 30, 2016 | 1.21 Bn |
| Mar 31, 2016 | 1.13 Bn |
| Dec 31, 2015 | 982.00 Mn |
| Sep 30, 2015 | 1.83 Bn |
| Jun 30, 2015 | 688.00 Mn |
| Mar 31, 2015 | 958.00 Mn |
| Dec 31, 2014 | 7.33 Bn |
| Sep 30, 2014 | 842.00 Mn |
| Jun 30, 2014 | 2.03 Bn |
| Mar 31, 2014 | 1.73 Bn |
| Dec 31, 2013 | 815.00 Mn |
| Sep 30, 2013 | 1.15 Bn |
| Jun 30, 2013 | 935.00 Mn |
| Mar 31, 2013 | 1.62 Bn |
| Dec 31, 2012 | 949.00 Mn |
| Sep 30, 2012 | 1.76 Bn |
| Jun 30, 2012 | 1.82 Bn |
| Mar 31, 2012 | 1.77 Bn |
| Dec 31, 2011 | 1.54 Bn |
| Sep 30, 2011 | 1.72 Bn |
| Jun 30, 2011 | 2.05 Bn |
| Mar 31, 2011 | 1.07 Bn |
| Dec 31, 2010 | -1.65 Bn |
| Sep 30, 2010 | 372.00 Mn |
| Jun 30, 2010 | 780.00 Mn |
| Mar 31, 2010 | 359.00 Mn |
| Dec 31, 2009 | 13.03 Bn |
| Sep 30, 2009 | -1.01 Bn |
| Jun 30, 2009 | 394.00 Mn |
| Mar 31, 2009 | 802.80 Mn |